ONTOLOGY REPORT - ANNOTATIONS
Term: amlodipine
Accession: CHEBI:2668
browse the term
Definition: A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Synonyms: exact_synonym: 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
related_synonym: 3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate; Amlodipine Free Base; C20H25ClN2O5; CCOC(=O)C1=C(COCCN)NC(C)=C(C1c1ccccc1Cl)C(=O)OC; InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3; InChIKey=HTIQEAQVCYTUBX-UHFFFAOYSA-N; amlodipino; amlodipinum
xref_casrn: 88150-42-9
xref: Beilstein:3570229 "Beilstein Registry Number"; ChEMBL:518414 "ChEMBL COMPOUND"; ChemIDplus:88150-42-9 "CAS Registry Number"; CiteXplore:1532771 "PubMed citation"; CiteXplore:16422032 "PubMed citation"; CiteXplore:1834846 "PubMed citation"; CiteXplore:19450066 "PubMed citation"; CiteXplore:21591999 "PubMed citation"; CiteXplore:7522286 "PubMed citation"; CiteXplore:8310972 "PubMed citation"; CiteXplore:8310973 "PubMed citation"; CiteXplore:9156957 "PubMed citation"; DrugBank:88150-42-9 "CAS Registry Number"; DrugBank:DB00381 "DrugBank"; KEGG COMPOUND:88150-42-9 "CAS Registry Number"; KEGG COMPOUND:C06825 "KEGG COMPOUND"; KEGG DRUG:88150-42-9 "CAS Registry Number"; KEGG DRUG:D07450 "KEGG DRUG"
xref_mesh: MESH:D017311
xref: Patent:EP89167 "Patent"; Patent:US4572909 "Patent"; Reaxys:3570229 "Reaxys Registry Number"; Wikipedia:Amlodipine "Wikipedia"
amlodipine
G
Ace
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
decreases expression
EXP
10
95,361,338
95,381,455
RGD:6480464
CTD
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression
ISO
11
79,908,291
79,911,065
RGD:6480464
CTD
G
Adipoq
adiponectin, C1Q and collagen domain containing
increases expression
ISO
11
79,908,291
79,911,065
RGD:6480464
CTD
G
Agt
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
multiple interactions
ISO
19
54,738,556
54,750,349
RGD:6480464
CTD
G
Agtr1a
angiotensin II receptor, type 1a
decreases expression
EXP
17
40,629,318
40,684,982
RGD:6480464
CTD
G
Agtr2
angiotensin II receptor, type 2
decreases expression
EXP
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
EXP
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
multiple interactions
EXP
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
EXP
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
multiple interactions
EXP
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bdkrb2
bradykinin receptor B2
increases response to substance
ISO
6
129,744,781
129,748,851
RGD:6480464
CTD
G
Casp3
caspase 3
multiple interactions
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
decreases cleavage
EXP
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp7
caspase 7
multiple interactions
ISO
1
262,689,300
262,721,591
RGD:6480464
CTD
G
Casp8
caspase 8
multiple interactions
ISO
9
57,389,353
57,437,803
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases expression
EXP
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccnd1
cyclin D1
multiple interactions
ISO
1
205,357,235
205,366,757
RGD:6480464
CTD
G
Ccne1
cyclin E1
decreases activity
ISO
1
90,568,189
90,577,426
RGD:6480464
CTD
G
Cdk2
cyclin dependent kinase 2
decreases activity
ISO
7
2,000,196
2,007,682
RGD:6480464
CTD
G
Cdk4
cyclin-dependent kinase 4
multiple interactions
ISO
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Col1a1
collagen, type I, alpha 1
decreases expression
EXP
10
83,622,438
83,639,368
RGD:6480464
CTD
G
Col1a2
collagen, type I, alpha 2
multiple interactions
EXP
4
29,393,645
29,428,572
RGD:6480464
CTD
G
Crp
C-reactive protein, pentraxin-related
multiple interactions
ISO
13
88,702,243
88,703,153
RGD:6480464
CTD
G
Ctsd
cathepsin D
multiple interactions
EXP
1
202,619,669
202,631,545
RGD:6480464
CTD
G
Ctsd
cathepsin D
multiple interactions
EXP
1
202,619,669
202,631,545
RGD:6480464
CTD
G
Ctsd
cathepsin D
multiple interactions
EXP
1
202,619,669
202,631,545
RGD:6480464
CTD
G
Cyba
cytochrome b-245, alpha polypeptide
multiple interactions
EXP
19
52,713,150
52,721,609
RGD:6480464
CTD
G
Cybb
cytochrome b-245, beta polypeptide
multiple interactions
EXP
X
25,514,572
25,547,181
RGD:6480464
CTD
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
decreases expression
EXP
8
61,793,976
61,805,308
RGD:6480464
CTD
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
8
61,462,207
61,468,237
RGD:6480464
CTD
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
decreases activity
ISO
1
81,345,425
81,359,415
RGD:6480464
CTD
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
affects response to substance
ISO
12
17,164,384
17,204,589
RGD:6480464
CTD
G
Drd1
dopamine receptor D1
multiple interactions
ISO
17
16,655,926
16,658,161
RGD:6480464
CTD
G
Drd2
dopamine receptor D2
multiple interactions
ISO
8
52,641,160
52,707,749
RGD:6480464
CTD
G
Edn1
endothelin 1
affects expression
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Gal
galanin/GMAP prepropeptide
multiple interactions
EXP
1
205,936,352
205,941,215
RGD:6480464
CTD
G
Gal
galanin/GMAP prepropeptide
multiple interactions
EXP
1
205,936,352
205,941,215
RGD:6480464
CTD
G
Gal
galanin/GMAP prepropeptide
multiple interactions
EXP
1
205,936,352
205,941,215
RGD:6480464
CTD
G
Gsr
glutathione reductase
decreases activity
EXP
16
62,255,562
62,298,458
RGD:6480464
CTD
G
Gusb
glucuronidase, beta
multiple interactions
EXP
12
27,744,409
27,757,755
RGD:6480464
CTD
G
Gusb
glucuronidase, beta
multiple interactions
EXP
12
27,744,409
27,757,755
RGD:6480464
CTD
G
Hspd1
heat shock protein 1 (chaperonin)
multiple interactions
EXP
9
53,884,193
53,895,043
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
multiple interactions
EXP
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
decreases expression
EXP
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Ins2
insulin 2
decreases expression
ISO
1
202,935,548
202,936,379
RGD:6480464
CTD
G
Jak2
Janus kinase 2
increases expression
ISO
1
232,915,995
232,974,763
RGD:6480464
CTD
G
Lep
leptin
decreases expression
ISO
4
55,943,837
55,945,938
RGD:6480464
CTD
G
Lep
leptin
decreases expression
ISO
4
55,943,837
55,945,938
RGD:6480464
CTD
G
Mt1a
metallothionein 1a
multiple interactions
EXP
19
11,261,631
11,262,647
RGD:6480464
CTD
G
Mtf1
metal-regulatory transcription factor 1
multiple interactions
EXP
5
144,135,674
144,180,430
RGD:6480464
CTD
G
Myh7
myosin, heavy chain 7, cardiac muscle, beta
decreases expression
EXP
15
33,072,928
33,094,595
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nox1
NADPH oxidase 1
multiple interactions
EXP
RGD:6480464
CTD
G
Nox4
NADPH oxidase 4
decreases expression
EXP
1
143,415,816
143,603,554
RGD:6480464
CTD
G
Nox4
NADPH oxidase 4
multiple interactions
EXP
1
143,415,816
143,603,554
RGD:6480464
CTD
G
Nppa
natriuretic peptide A
decreases expression
EXP
5
165,074,518
165,075,827
RGD:6480464
CTD
G
Olr1
oxidized low density lipoprotein (lectin-like) receptor 1
multiple interactions
ISO
4
166,747,228
166,769,340
RGD:6480464
CTD
G
Ppbp
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
decreases expression
ISO
14
18,816,434
18,817,238
RGD:6480464
CTD
G
Rb1
retinoblastoma 1
decreases phosphorylation
ISO
15
53,828,881
53,962,099
RGD:6480464
CTD
G
Ren
renin
multiple interactions
ISO
13
46,262,936
46,275,213
RGD:6480464
CTD
G
Retn
resistin
decreases expression
ISO
12
2,499,630
2,501,370
RGD:6480464
CTD
G
Selp
selectin P
decreases expression
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Smad2
SMAD family member 2
multiple interactions
ISO
18
73,180,520
73,241,707
RGD:6480464
CTD
G
Smad4
SMAD family member 4
multiple interactions
ISO
18
70,432,705
70,461,541
RGD:6480464
CTD
G
Sod1
superoxide dismutase 1, soluble
multiple interactions
EXP
11
29,810,766
29,816,342
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
1
80,894,705
80,911,020
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
1
80,894,705
80,911,020
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
decreases response to substance
ISO
1
80,894,705
80,911,020
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
multiple interactions
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases expression
EXP
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
EXP
2
212,277,654
212,297,376
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest